搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
HealthDay on MSN
12 小时
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced perip ...
KELOLAND News
1 天
Axiom Chiropractic and Neuropathy: A leg, foot, and mobility clinic
Peripheral neuropathy: a condition that can cause tingling, numbness, and pain in the extremities, especially the feet and ...
Medindia
6 天
Neuropathy: Persistent Nerve Pain Affects 40% of Cancer Patients on Chemotherapy
Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...
Health and Me on MSN
6 天
Chemotherapy Can Lead To Nerve Damage Called The Peripheral Neuropathy, Know What It Means
Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...
3 小时
Hands On Diagnostics Study Finds A Groundbreaking Approach to Treating Neuropathy with the ...
NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...
7 天
on MSN
Many cancer patients experience nerve pain from chemo
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
News Medical on MSN
7 天
Cancer drugs linked to severe chronic peripheral nerve pain for 4 in every 10 patients in ...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...
Scientific American
5 天
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Managed Healthcare Executive
4 天
FDA Approves Journavx, New Nonopioid Med, for Acute Pain
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...
News Medical on MSN
4 天
Pain coping skills training reduces pain and improves quality of life for dialysis patients
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
13 天
on MSN
Rosedale Acupuncture & Wellness: Relief for Peripheral Neuropathy
Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with chronic pain conditions, including peripheral neuropathy. You treat ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈